Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Application
Filed:
June 26, 2014
Publication date:
September 8, 2016
Inventors:
William MESSER, Ralph BARIC, Aravinda DE SILVA, Boyd YOUNT
Abstract: The invention provides immunogenic formulations comprising virus-like particles (VLPs) from two or more genoclusters and/or strains of norovirus in a pharmaceutically acceptable carrier. In representative embodiments, the formulation also comprises an adjuvant, for example, a viral adjuvant or CpG. The invention also provides methods of inducing an immune response to one or more noroviruses.
Type:
Application
Filed:
September 3, 2010
Publication date:
March 24, 2011
Inventors:
Ralph S. Baric, Anna LoBue, Robert Edward Johnston, Joseph Thompson, Lisa Lindesmith
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Application
Filed:
August 20, 2018
Publication date:
July 25, 2019
Inventors:
William Messer, Ralph Baric, Aravinda de Silva, Boyd Yount
Abstract: A filled two-piece aluminum can contains a wine that has less than 35 ppm of free SO2, less than 300 ppm of chlorides, less than 800 ppm of sulfates, and less than 250 ppm of total sulfur dioxide. The can is sealed with an aluminum closure such that the pressure within the can is at least 25 psi. The inner surface of the aluminum can is coated with a corrosion resistant coating.
Abstract: A vending machine has a housing with a first side and a second side opposite the first side. A first dispensing slot is located at the first side of the housing, and a second dispensing slot is located at the second side of the housing. A central product storage stores product to be dispensed from the vending machine. A product delivery system selectively delivers product from said product storage to the first dispensing slot and said second dispensing slot.
Abstract: A vending machine has a housing with a first side and a second side opposite the first side. A first dispensing slot is located at the first side of the housing, and a second dispensing slot is located at the second side of the housing. A central product storage stores product to be dispensed from the vending machine. A product delivery system selectively delivers product from said product storage to the first dispensing slot and said second dispensing slot.
Abstract: A vending machine has a housing with a first side and a second side opposite the first side. A first dispensing slot is located at the first side of the housing, and a second dispensing slot is located at the second side of the housing. A central product storage stores product to be dispensed from the vending machine. A product delivery system selectively delivers product from said product storage to the first dispensing slot and said second dispensing slot.
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Grant
Filed:
August 20, 2018
Date of Patent:
December 22, 2020
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
William Messer, Ralph Baric, Aravinda de Silva, Boyd Yount
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Grant
Filed:
June 26, 2014
Date of Patent:
August 21, 2018
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
William Messer, Ralph Baric, Aravinda de Silva, Boyd Yount
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce a dengue virus E glycoprotein epitope from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Application
Filed:
May 23, 2018
Publication date:
May 21, 2020
Inventors:
Ralph BARIC, Matthew BEGLEY, Douglas WIDMAN, Aravinda DESILVA, Usha NIVARTHI, Boyd YOUNT, Ellen YOUNG
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Application
Filed:
November 2, 2015
Publication date:
November 23, 2017
Inventors:
Ralph Baric, Douglas Widman, Boyd Yount, Emily Gallichotte, Scott Royal, Aravinda Desilva, Jesica Swanstrom
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Application
Filed:
August 29, 2019
Publication date:
July 23, 2020
Inventors:
Ralph Baric, Douglas Widman, Boyd Yount, Emily Gallichotte, Scott Royal, Aravinda Desilva, Jesica Swanstrom
Abstract: A method of producing a green compact which includes the steps of forming a generally homogeneous powder blend of powder components; consolidating the powder blend into a green body wherein the green body includes a flashing; impinging the green body with a fluid stream so as to dislodge the flashing; and removing the dislodged flashing from the surface of the green body.
Type:
Grant
Filed:
November 4, 1997
Date of Patent:
September 22, 1998
Assignee:
Kennametal Inc.
Inventors:
William R. Shaffer, Thomas J. Baric, Daniel Danila, Robert L. Macabobby
Abstract: A method of filling an aluminium container with wine, and a filled aluminium container containing a wine characterised in that the maximum oxygen content of the head space is 1% v/v and the wine prior to filling is micro filtered and dissolved oxygen levels throughout the aluminium container filling process are maintained up to 0.5 mg/L. and final levels of dissolved CO2 are from 50 ppm for white and sparkling wines and from 50 ppm to 400 ppm for red wines, prior to filling the container.
Type:
Application
Filed:
January 15, 2016
Publication date:
July 14, 2016
Inventors:
Gregory John Charles Stokes, Steven John Anthony Barics
Abstract: The present invention provides a cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles. Also provided are methods of making the compositions of this invention and methods of using the compositions as immunogens and/or vaccines and/or to express heterologous nucleic acids.
Type:
Grant
Filed:
January 19, 2006
Date of Patent:
November 17, 2009
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
Ralph S. Baric, Rhonda Roberts, Boyd Yount, Kristopher M. Curtis
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce a dengue virus E glycoprotein epitope from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Grant
Filed:
May 23, 2018
Date of Patent:
February 8, 2022
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
Ralph Baric, Matthew Begley, Douglas Widman, Aravinda Desilva, Usha Nivarthi, Boyd Yount, Ellen Young
Abstract: Provided is an actuator, preferably a linear actuator, including a carriage having a lateral support surface for supporting a first longitudinal section of a belt against lateral deflection and a space adjacent to and longitudinally offset from the lateral support surface for partially surrounding a second longitudinal section of the belt that is deflected relative to the lateral support surface to take up slack and/or tension the belt. By containing the slack within the carriage using the space and the lateral support surface, slack may be removed from the belt or the belt may be tensioned in an easy and cost efficient manner.
Type:
Application
Filed:
March 26, 2019
Publication date:
July 18, 2019
Inventors:
Thomas BARIC, Mike BRIDGES, Adis HALIMIC
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce an epitope that is recognized by an antibody from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Grant
Filed:
November 2, 2015
Date of Patent:
September 3, 2019
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
Ralph Baric, Douglas Widman, Boyd Yount, Emily Gallichotte, Scott Royal, Aravinda Desilva, Jesica Swanstrom
Abstract: A linear table includes a slide plate, a base, and pair of bearing assemblies. Each bearing assembly has an inner and outer bearing way, and a rolling element located between the bearing ways. The bearing ways are securely fixed to the slide plate and the base. A precision parallel device and preload fixture are used to align the bearing ways and provide a proper preload on the bearing assemblies without integral preload screws or other preload method, or integral bearing locating shoulders or other such geometry.
Type:
Application
Filed:
August 28, 2003
Publication date:
May 6, 2004
Inventors:
Thomas J. Baric, James K. Monnich, Jeremy F. Mikesell, Mark S. Koster
Abstract: The present invention provides compositions and methods of use comprising a chimeric dengue virus E glycoprotein comprising a dengue virus E glycoprotein backbone, which comprises amino acid substitutions that introduce a dengue virus E glycoprotein domain I and domain II hinge region from a dengue virus serotype that is different from the dengue virus serotype of the dengue virus E glycoprotein backbone.
Type:
Application
Filed:
March 15, 2013
Publication date:
November 19, 2015
Inventors:
Aravinda M. De Silva, A. Ruklanthi De Alwis, Wahala M.P.B. Wahala, Ralph H. Baric, William B. Messer, James E. Crowe, Scott A. Smith